Bicara Therapeutics (BCAX)'s 30-day implied volatility (IV30) was 69.7% at the close on November 4, 2026, up from 67.0% the day before, against a 52-week range of 34.4% to 98.5%. Its 20-day historical volatility was 76.4%.
Data as of November 4, 2026.